Subirà, Maricel <br/><br/>
Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.  [electronic resource] 

 -  European journal of haematology  May 2004 
 - 342-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0902-4441 
<br/><br/><label>Standard No.: </label>10.1111/j.1600-0609.2004.00239.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Amphotericin B--administration & dosage<br/>Antifungal Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Chemical and Drug Induced Liver Injury--etiology<br/>Combined Modality Therapy<br/>Drug Combinations<br/>Female<br/>Fever of Unknown Origin--etiology<br/>Hematologic Neoplasms--complications<br/>Humans<br/>Hypokalemia--chemically induced<br/>Immunocompromised Host<br/>Incidence<br/>Kidney Diseases--chemically induced<br/>Male<br/>Middle Aged<br/>Mycoses--drug therapy<br/>Neutropenia--chemically induced<br/>Peripheral Blood Stem Cell Transplantation--adverse effects<br/>Phosphatidylcholines--administration & dosage<br/>Phosphatidylglycerols--administration & dosage<br/>Treatment Outcome